Search research articles
Contact Us
Filters
Showing results (41-50 of 71) with videos related to
Page
of 8
Sort By:
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
March 20, 2018
Intelligent and effective informatic deconvolution of "Big Data" and its future impact on the quantitative nature of neurodegenerative disease therapy
Stuart Maudsley, Viswanath Devanarayan, Bronwen Martin, et al.
European Journal of Pharmacology
|
June 7, 2017
Towards the virtual human patient. Quantitative Systems Pharmacology in Alzheimer's disease
Hugo Geerts, Athan Spiros, Patrick Roberts, et al.
Science of Aging Knowledge Environment : SAGE KE
|
February 11, 2005
Drug discovery in neurodegenerative diseases
Hugo Geerts, John Q Trojanowski, Virginia M-Y Lee
Journal of Alzheimer'S Disease : JAD
|
July 28, 2007
Beyond in vitro data: a review of in vivo evidence regarding the allosteric potentiating effect of galantamine on nicotinic acetylcholine receptors in Alzheimer's neuropathology
Joseph T Coyle, Hugo Geerts, Karin Sorra, et al.
Frontiers in Pharmacology
|
October 20, 2023
Editorial: Innovative pharmacometric approaches to inform drug development and clinical use
Maria Garcia-Cremades, Zinnia P Parra-Guillen, Victor Mangas-Sanjuan, et al.
Journal of Pharmacokinetics and Pharmacodynamics
|
July 28, 2023
Computational neurosciences and quantitative systems pharmacology: a powerful combination for supporting drug development in neurodegenerative diseases
Hugo Geerts, Silke Bergeler, William W Lytton, et al.
Frontiers in Pharmacology
|
May 18, 2026
Understanding quantitative effects of anti-amyloid therapies on tau biomarkers and functional outcome. Insights from a comprehensive mechanistic quantitative systems pharmacology study
Hugo Geerts, Shaina M Short, Athena Grant, et al.
Brain Research
|
February 8, 2005
Brain levels and acetylcholinesterase inhibition with galantamine and donepezil in rats, mice, and rabbits
Hugo Geerts, Pierre-Olivier Guillaumat, Christopher Grantham, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
June 22, 2016
Big data to smart data in Alzheimer's disease: Real-world examples of advanced modeling and simulation
Magali Haas, Diane Stephenson, Klaus Romero, et al.
Plos One
|
December 20, 2012
Blinded prospective evaluation of computer-based mechanistic schizophrenia disease model for predicting drug response
Hugo Geerts, Athan Spiros, Patrick Roberts, et al.
Page
of 8
Search research articles
Search
Showing results (41-50 of 71) with videos related to
Sort By:
Page
of 8
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
March 20, 2018
Intelligent and effective informatic deconvolution of "Big Data" and its future impact on the quantitative nature of neurodegenerative disease therapy
Stuart Maudsley, Viswanath Devanarayan, Bronwen Martin, et al.
European Journal of Pharmacology
|
June 7, 2017
Towards the virtual human patient. Quantitative Systems Pharmacology in Alzheimer's disease
Hugo Geerts, Athan Spiros, Patrick Roberts, et al.
Science of Aging Knowledge Environment : SAGE KE
|
February 11, 2005
Drug discovery in neurodegenerative diseases
Hugo Geerts, John Q Trojanowski, Virginia M-Y Lee
Journal of Alzheimer'S Disease : JAD
|
July 28, 2007
Beyond in vitro data: a review of in vivo evidence regarding the allosteric potentiating effect of galantamine on nicotinic acetylcholine receptors in Alzheimer's neuropathology
Joseph T Coyle, Hugo Geerts, Karin Sorra, et al.
Frontiers in Pharmacology
|
October 20, 2023
Editorial: Innovative pharmacometric approaches to inform drug development and clinical use
Maria Garcia-Cremades, Zinnia P Parra-Guillen, Victor Mangas-Sanjuan, et al.
Journal of Pharmacokinetics and Pharmacodynamics
|
July 28, 2023
Computational neurosciences and quantitative systems pharmacology: a powerful combination for supporting drug development in neurodegenerative diseases
Hugo Geerts, Silke Bergeler, William W Lytton, et al.
Frontiers in Pharmacology
|
May 18, 2026
Understanding quantitative effects of anti-amyloid therapies on tau biomarkers and functional outcome. Insights from a comprehensive mechanistic quantitative systems pharmacology study
Hugo Geerts, Shaina M Short, Athena Grant, et al.
Brain Research
|
February 8, 2005
Brain levels and acetylcholinesterase inhibition with galantamine and donepezil in rats, mice, and rabbits
Hugo Geerts, Pierre-Olivier Guillaumat, Christopher Grantham, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
June 22, 2016
Big data to smart data in Alzheimer's disease: Real-world examples of advanced modeling and simulation
Magali Haas, Diane Stephenson, Klaus Romero, et al.
Plos One
|
December 20, 2012
Blinded prospective evaluation of computer-based mechanistic schizophrenia disease model for predicting drug response
Hugo Geerts, Athan Spiros, Patrick Roberts, et al.
Page
of 8